Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced a supplementary disclosure regarding its acquisition of an 11.04% equity interest in a target company. The transaction involves a significant financial stake, with the book value of the equity attributable to the target shares being over 867 million RMB as of June 2025. The seller, AHAPL, is now indirectly owned by Blazing Star Investors, LLC, following a privatization and restructuring of its former parent company, Walgreens Boots Alliance. This acquisition is expected to impact the company’s market positioning and potential growth opportunities.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company with limited liability established in the People’s Republic of China. The company operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products.
Average Trading Volume: 1,673,233
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.33B
See more data about 0874 stock on TipRanks’ Stock Analysis page.